Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
43 Results Found
AHA Summary of Hospital Inpatient PPS Proposed Rule for Fiscal Year 2023
The Centers for Medicare & Medicaid Services (CMS) April 18 issued its hospital inpatient prospective payment system (PPS) and long-term care hospital (LTCH) PPS proposed rule for fiscal year (FY) 2023.
AHA, AHRQ release toolkit to help hospitals prevent ICU infections
The customizable toolkit offers resources to help prevent central line-associated bloodstream infections and catheter-associated urinary tract infections.
Thanks You | CDI Prevention Collaborative | Center
Thank you for submitting your information to the CDI Prevention Collaborative. We will review and get back to you to discuss next steps.
CDC issues guidance on treating drug-resistant typhoid fever
The Centers for Disease Control and Prevention released recommendations for treating Extensively Drug-Resistant Salmonella Typhi, a systemic illness transmitted through contaminated food and water and person-to-person contact.
Registration Form | CDI Prevention Collaborative | Center
The CDI Prevention Collaborative is a rigorous national change effort working to develop, test and implement sustainable and scalable best practices to reduce C. difficile infections.
Certified Surgical Cleaning Technician Virtual Train-the-Trainer Workshop (CSCT)
Using the train-the-trainer model, the Certified Surgical Cleaning Technician (CSCT) program prepares trainers to conduct certification training for surgical cleaning technicians, ensuring they are
Certificate in Non-acute Care Cleaning Train-the-Trainer Workshop (CNACC)
Introductory pricing for 2020 is offered.
The Laboratory’s Role in Improving C. difficile Rates
In the fight against Clostridioides difficile (C. diff; formerly known as Clostridium difficile), hospitals have become
extra vigilant about rapidly diagnosing and treating infected patients.
FDA announces voluntary tetracycline recall
The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.
AHE 2019 Webinar: How Bacteria Develop Antibiotic Resistance
Websites
This webinar will provide an in-depth explanation of how organisms develop drug resistance, and what we can do to reduce this growth.